Blueberry Therapeutics articles

Blueberry were recently invited to write two commentaries on the challenges of treating skin and nail diseases and the potential for nanotechnology approaches in dermal drug delivery. Here we share a brief overview of these articles.

We will all have encountered someone who is dealing with or has previously experienced a common ailment of the skin or nails, such as eczema (atopic dermatitis), acne, athlete’s foot (tinea pedis), or a fungal nail infection (onychomycosis)

Blueberry Therapeutics hopes to make a real difference to the quality of life for people who suffer from skin and nail conditions by curing the symptoms they experience. To do this, it is key to understand exactly what issues affect people with these conditions, how this makes them feel, and how much this impacts their daily way of life.

Our most advanced area of research is fungal infection of the nails, also called onychomycosis, which leads to thickening, splitting, roughening, dis

Blueberry Therapeutics is a drug development company committed to finding new and improved treatments for a range of dermatological conditions affecting the skin and nails. The future and long-term effect of the global COVID-19 pandemic (caused by severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2 virus]) on dermatology practice and skin health is still unknown, but here we provide some insights on the potential challenges for dermatology patients and practitioners.